[1]
Günaydın, S. et al. 2026. Factors Affecting Mortality in COVID-19 Pneumonia Patients Treated with Tocilizumab. The European Research Journal. 12, 7 (May 2026), 780–788. DOI:https://doi.org/10.18621/eurj.1829791.